Pharmaceutical dosage form

a technology dosage forms, applied in the direction of drug compositions, nervous disorders, transportation and packaging, etc., can solve the problems of serious adverse effects or even death, particularly unpleasant, and has indeed proved rather unsatisfactory, and achieves fine adjustment or tailoring, accurate, predictable and reliable manner, and greater control of the release profile of pharmaceutically active ingredients
US20130251759A1Inactive Publication Date: 2013-09-26GRUNENTHAL GMBH
6 Cites 20 Cited by

Patent Information

Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
GRUNENTHAL GMBH
Publication Date
2013-09-26
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a pharmaceutical dosage form, preferably with controlled release of a pharmacologically active compound (A) contained therein, the pharmaceutical dosage form very preferably being tamper-resistant and most preferably having a breaking strength B1 of at least 500 N in direction of extension E1 and having a breaking strength B2 of less than 500 N in direction of extension E2.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a division of U.S. patent application Ser. No. 12 / 358,415 filed Jan. 23, 2009, now allowed, which claims foreign priority of European Patent Application No. 08018221.5 filed Oct. 17, 2008; European Patent Application No. 08001416.0 filed Jan. 25, 2008; and European Patent Application No. 08001415.2 filed Jan. 25, 2008, the disclosures of which are incorporated herein by reference.FIELD OF THE INVENTION

[0002] The invention relates to a pharmaceutical dosage form, preferably a tablet for oral administration.BACKGROUND ART

[0003] For many pharmaceutically active compounds it is still preferred to have them orally administered by way of tablets. It is also well known that depending on how a pharmaceutically active ingredient is formulated into a tablet its release pattern can be modified. In this regard, tablets providing a retarded release profile are of primary importance. With retarded release tablets care has to be taken that under no circumstances the pharmac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More